{"entity":{"id":"shanghai-pulmonary-hospital","kind":"institution","name":"Shanghai Pulmonary Hospital","aka":["Shanghai Pulmonary Hospital, Tongji University","上海市肺科医院"],"tldr":"Shanghai Pulmonary Hospital is a lung-only hospital with one of the largest thoracic surgery volumes anywhere; Caicun Zhou's medical oncology department was the Chinese lead site for the first-generation EGFR inhibitor trials and for camrelizumab, sintilimab and tislelizumab combinations in lung cancer.","summary":"Shanghai Pulmonary Hospital, affiliated to Tongji University, is a national clinical research centre for lung disease and one of the highest-volume thoracic surgery centres anywhere, known for uniportal and robotic lobectomy and for large early-stage screening cohorts. Caicun Zhou's Department of Medical Oncology has been the Chinese lead site for first-generation EGFR inhibitor trials, camrelizumab, sintilimab and tislelizumab combinations, and ADC studies in NSCLC. The hospital publishes extensively on ground-glass nodules, minimally invasive surgery and the molecular epidemiology of lung cancer in never-smokers.","asOf":"2026-09-09","wikipedia":"https://en.wikipedia.org/wiki/Shanghai_Pulmonary_Hospital","links":[{"label":"Shanghai Pulmonary Hospital","url":"https://www.shsfkyy.com"},{"label":"Tongji University","url":"https://www.tongji.edu.cn"}],"tags":[],"related":[],"cancers":["nsclc","sclc"],"sections":["targeted-therapy","immunotherapy","early-detection"],"technologies":["checkpoint-inhibitor","kinase-inhibitors","robotic-surgery","ct"],"targets":["egfr","pd1","alk"],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":["zhou-caicun"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Shanghai","country":"CN","lat":31.29,"lng":121.48,"institutionType":"hospital","website":"https://www.shsfkyy.com","university":"Tongji University","programs":["Lung cancer medical oncology trials","Thoracic surgery","Lung nodule management"]},"route":"/institutions/shanghai-pulmonary-hospital/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"sclc","kind":"cancer","name":"Small-cell lung cancer","route":"/cancers/sclc/"}],"section":[{"id":"early-detection","kind":"section","name":"Early Detection & Screening","route":"/fronts/early-detection/"},{"id":"immunotherapy","kind":"section","name":"Immunotherapy","route":"/fronts/immunotherapy/"},{"id":"targeted-therapy","kind":"section","name":"Targeted Therapy","route":"/fronts/targeted-therapy/"}],"technology":[{"id":"ct","kind":"technology","name":"CT (computed tomography)","route":"/technologies/ct/"},{"id":"checkpoint-inhibitor","kind":"technology","name":"Immune checkpoint inhibitors","route":"/technologies/checkpoint-inhibitor/"},{"id":"robotic-surgery","kind":"technology","name":"Robotic & minimally invasive surgery","route":"/technologies/robotic-surgery/"},{"id":"kinase-inhibitors","kind":"technology","name":"Small-molecule kinase inhibitors","route":"/technologies/kinase-inhibitors/"}],"target":[{"id":"alk","kind":"target","name":"ALK","route":"/targets/alk/"},{"id":"egfr","kind":"target","name":"EGFR","route":"/targets/egfr/"},{"id":"pd1","kind":"target","name":"PD-1","route":"/targets/pd1/"}],"person":[{"id":"zhou-caicun","kind":"person","name":"Caicun Zhou","route":"/people/zhou-caicun/"}]}}